AC Immune (ACIU) Payables (2014 - 2026)

AC Immune (ACIU) has 13 years of Payables data on file, last reported at $1.7 billion in Q1 2026.

• On a quarterly basis, Payables rose 63236.65% year-over-year to $1.7 billion in Q1 2026; TTM through Mar 2026 was $1.7 billion, a 63236.65% increase from a year earlier, with the FY2025 full-year figure at $2.5 billion, up 82106.26% from the prior year.
• Payables for Q1 2026 stood at $1.7 billion, down from $2.6 billion in the prior quarter.
• Over the last five years, Payables for ACIU reached as high as $2.6 billion in Q4 2025 and fell as low as $964322.4 in Q4 2022.
• Historically, Payables has averaged $416.6 million across 5 years, with a median of $2.7 million in 2025.
• Across the five-year window, Payables tumbled 99.96% in 2022 and jumped 196185.83% in 2023, its largest moves.
• Year by year, Payables stood at $964322.4 in 2022, then jumped by 196185.83% to $1.9 billion in 2023, then slumped by 99.84% to $3.0 million in 2024, then soared by 85176.15% to $2.6 billion in 2025, then sank by 34.9% to $1.7 billion in 2026.
• Per Business Quant data, the three most recent Payables figures were $1.7 billion in Q1 2026, $2.6 billion in Q4 2025, and $2.0 million in Q3 2025.